Jan Hendrik Frenking

8PUBLICATIONS
51CO-AUTHORS
Medical mycologyHaematological tumoursHybrid and electric vehicles and powertrainsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.

Lilli Sophie Sester, Iuliia Galeeva, Juliana de Castilhos

|Feb 13, 2026
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy.

Jan H Frenking, Christine Riedhammer, Thomas Hielscher

|Dec 22, 2025
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

Martin Grözinger, Muriel Schlanke, Jana Gröne

|Nov 11, 2025
The CAR-HEMATOTOX: ready for prime time.

Jan H Frenking, Kai Rejeski

|Jul 11, 2025
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.

Tim Richardson, Udo Holtick, Jan-Hendrik Frenking

|Apr 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma.

Jan H Frenking, Xiang Zhou, Kai Rejeski

Pageof 2

Frequent Collaborators

4 joint publications

Elias K Mai

4 joint publications

Marc S Raab

4 joint publications

Carsten Müller-Tidow

3 joint publications

Hartmut Goldschmidt